Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Bronchopneumonia D001996 7 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Burns D002056 34 associated lipids
Byssinosis D002095 11 associated lipids
Carbon Monoxide Poisoning D002249 9 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Cat Diseases D002371 12 associated lipids
Cattle Diseases D002418 24 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Tishler M et al. Salivary eicosanoid concentration in patients with Sjögren's syndrome. 1996 Ann. Rheum. Dis. pmid:8712887
Katz JM et al. Inhibition of prostaglandin action and bone resorption by copper. 1984 Ann. Rheum. Dis. pmid:6441529
Salmon JA et al. Synthesis of arachidonate cyclo-oxygenase products by rheumatoid and nonrheumatoid synovial lining in nonproliferative organ culture. 1983 Ann. Rheum. Dis. pmid:6402992
Doube A et al. Effect of misoprostol on concentrations of prostaglandins in synovial fluid. 1991 Ann. Rheum. Dis. pmid:1772296
Diven WF et al. Expression of acute otitis media after receptor blockade of platelet activating factor, thromboxane, and leukotrienes in the chinchilla. 1998 Ann. Otol. Rhinol. Laryngol. pmid:9525240
Ferry DR et al. A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints. 2000 Ann. Oncol. pmid:11061613
Elmadfa I et al. Influence of a single parenteral application of a 10% fish oil emulsion on plasma fatty acid pattern and the function of thrombocytes in young adult men. 1993 Ann. Nutr. Metab. pmid:8470873
Cunnane SC Vitamin E intake affects serum thromboxane and tissue essential fatty acid composition in the rat. 1988 Ann. Nutr. Metab. pmid:3214140
Quoc KP and Pascaud M Effects of dietary gamma-linolenic acid on the tissue phospholipid fatty acid composition and the synthesis of eicosanoids in rats. 1996 Ann. Nutr. Metab. pmid:8773734
Masi I et al. Diets rich in saturated, monounsaturated and polyunsaturated fatty acids differently affect plasma lipids, platelet and arterial wall eicosanoids in rabbits. 1986 Ann. Nutr. Metab. pmid:3513691
Pratico D et al. Cyclooxygenase-dependent formation of the isoprostane 8-epi prostaglandin F2 alpha. 1994 Ann. N. Y. Acad. Sci. pmid:7825834
Feuerstein G Eicosanoids in deteriorating stroke. Review of studies on the rabbit spinal cord ischemia and reperfusion model. 1989 Ann. N. Y. Acad. Sci. pmid:2774403
Panganamala RV and Cornwell DG The effects of vitamin E on arachidonic acid metabolism. 1982 Ann. N. Y. Acad. Sci. pmid:6816121
Hansen TN and Carpenter JF The role of platelets in chilling-induced injury. 1994 Ann. N. Y. Acad. Sci. pmid:8017779
Wong PY et al. The role of calmodulin in prostaglandin metabolism. 1980 Ann. N. Y. Acad. Sci. pmid:6940495
Gryglewski RJ et al. Prostacyclin, nitric oxide, and atherosclerosis. 1995 Ann. N. Y. Acad. Sci. pmid:7695165
Numano F et al. Prostacyclin and variant angina. 1985 Ann. N. Y. Acad. Sci. pmid:3865605
Jesse RL et al. Dehydroepiandrosterone inhibits human platelet aggregation in vitro and in vivo. 1995 Ann. N. Y. Acad. Sci. pmid:8597466
Hartung HP et al. Substance P stimulates release of arachidonic acid cyclooxygenation products from primary culture rat astrocytes. 1988 Ann. N. Y. Acad. Sci. pmid:2462817
Takami M et al. Effect of DP-1904, a new thromboxane A2 synthetase inhibitor, on guinea pig experimental asthma. 1991 Ann. N. Y. Acad. Sci. pmid:1952565
Crinnion JN et al. Neutrophils and the endothelium in post-ischemic alterations in skeletal muscle blood flow. 1994 Ann. N. Y. Acad. Sci. pmid:8030907
Osterud B and Hansen JB Fatty acids, platelets and monocytes. Something to do with atherogenesis. 1989 Ann. Med. pmid:2923703
Emanuelli G et al. [Effects of anti-adrenergic drugs on thrombin-induced platelet aggregation and thromboxane B2 production]. 1988 Oct-Dec Ann. Ital. Med. Int. pmid:3275193
Lee M et al. Dose effects of aspirin on gastric prostaglandins and stomach mucosal injury. 1994 Ann. Intern. Med. pmid:8273981
Whelton A et al. Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. A prospective, randomized, crossover comparison. 1990 Ann. Intern. Med. pmid:2183665
Elias M et al. Stabilization of standard platelet concentrates and minimization of the platelet storage lesion by a prostacyclin analogue. 1992 Ann. Hematol. pmid:1379080
Nordøy A Lipids and thrombogenesis. 1981 Ann. Clin. Res. pmid:7018362
Ylikorkala O Prostanoids in gynaecology. 1984 Ann. Clin. Res. pmid:6398666
Vapaatalo H et al. Prostanoids in blood pressure regulation and their role in the blood pressure lowering effects induced by changes in dietary fats. 1984 Ann. Clin. Res. pmid:6398981
Morris RH and Davies GG Thin layer chromatographic identification of thromboxane B2 in serum, and platelet rich plasma stimulated by arachidonic acid and collagen. 1993 Ann. Clin. Biochem. pmid:8466155
Fukushima C et al. In vitro responses to antigen stimulation: comparison between human lung parenchyma resected from asthmatic patients and non-asthmatic patients. 1999 Ann. Allergy Asthma Immunol. pmid:10071522
Zhao Y et al. Effect of a Chinese herbal formula, Shi-Bi-Lin, on an experimental model of allergic rhinitis. 2006 Ann. Allergy Asthma Immunol. pmid:16802773
Fukushima C et al. Effect of synthetase inhibitors and receptor antagonists in antigen-induced contraction of human lung parenchyma. 1998 Ann. Allergy Asthma Immunol. pmid:9532973
Takao A et al. Inhibitory effects of azelastine hydrochloride in alcohol-induced asthma. 1999 Ann. Allergy Asthma Immunol. pmid:10227338
Fukushima C et al. Inhibitory effect of thromboxane A2 synthetase inhibitor, DP-1904, on antigen-induced contraction of human lung parenchyma. 1996 Ann. Allergy Asthma Immunol. pmid:8970439
Paterson IS et al. Reperfusion plasma contains a neutrophil activator. 1993 Ann Vasc Surg pmid:8390848
Ascer E et al. Interleukin-1 and thromboxane release after skeletal muscle ischemia and reperfusion. 1992 Ann Vasc Surg pmid:1547081
Angel MF et al. The effect of prior elevation of skin flaps and ischemia on blood thromboxane levels. 1989 Ann Plast Surg pmid:2751221
Edstrom LE et al. Effect of ischemic skin flap elevation on tissue and plasma thromboxane A2 and prostacyclin production: modification by thromboxane synthetase inhibition. 1988 Ann Plast Surg pmid:3281544
Mohri H and Ohkubo T Single-dose effect of enteric-coated aspirin on platelet function and thromboxane generation in middle-aged men. 1993 Ann Pharmacother pmid:8477113
Tanen DA et al. Comparison of oral aspirin versus topical applied methyl salicylate for platelet inhibition. 2008 Ann Pharmacother pmid:18698012
Lin TY et al. The effect of YAG laser anterior capsulotomy on prostaglandin concentration in aqueous humor. 1988 Ann Ophthalmol pmid:3400958
Kivioja A et al. Platelet activation during acute phase after multiple trauma. 1992 Ann Chir Gynaecol pmid:1456710
Nishikata H et al. Induction of bronchial hyperresponsiveness by Bordetella bronchiseptica infection in dogs. 1989 Ann Allergy pmid:2643371
Numano F et al. Antiaggregative aspirin dosage at the affected vessel wall. 1986 Angiology pmid:2876664
Bölke E et al. Changes of gut barrier function during anesthesia and cardiac surgery. 2001 Angiology pmid:11515987
Mikhailidis DP et al. Platelet function in patients admitted with a diagnosis of myocardial infarction. 1987 Angiology pmid:2880535
Vissinger H et al. Platelet-derived growth factor release and antiplatelet treatment with low-dose acetylsalicylic acid. 1993 Angiology pmid:8342880
Saitta A et al. Effects of picotamide on release of endothelin-1, thromboxane and prostacycline after treadmill stress in patients with peripheral artery disease. 1998 Angiology pmid:9822043
Jean T and Bodinier MC Mediators involved in inflammation: effects of Daflon 500 mg on their release. 1994 Angiology pmid:8203787
Nichols WW et al. Reduced myocardial neutrophil accumulation and infarct size following thromboxane synthetase inhibitor or receptor antagonist. 1989 Angiology pmid:2537051
Sinzinger H et al. Platelet half-life, plasma thromboxane B2 and circulating endothelial-cells in peripheral vascular disease. 1986 Angiology pmid:3954150
Nagano H et al. Cerebral microcirculatory changes after cerebral embolization induced by glass bead injection in rabbits. 1992 Angiology pmid:1632571
Takase B et al. Arachidonic acid metabolites in acute myocardial infarction. 1996 Angiology pmid:8686958
Oda H et al. Alcohol and coronary spasm. 1994 Angiology pmid:8129199
Kurita A et al. The effects of orally administered atenolol on the coronary hemodynamics and prostaglandin metabolism in angina pectoris patients. 1994 Angiology pmid:8129203
Fujinishi A et al. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease. 1997 Angiology pmid:9194537
Gama de Abreu M et al. Vaporized perfluorohexane attenuates ventilator-induced lung injury in isolated, perfused rabbit lungs. 2005 Anesthesiology pmid:15731599
Sheu JR et al. Mechanisms involved in the antiplatelet activity of midazolam in human platelets. 2002 Anesthesiology pmid:11873041
Lowenstein E and Zapol WM Protamine reactions, explosive mediator release, and pulmonary vasoconstriction. 1990 Anesthesiology pmid:2393123
Morel DR et al. Adverse cardiopulmonary effects and increased plasma thromboxane concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent. 1990 Anesthesiology pmid:2098007
Hirakata H et al. Sevoflurane inhibits human platelet aggregation and thromboxane A2 formation, possibly by suppression of cyclooxygenase activity. 1996 Anesthesiology pmid:8968193
Shayevitz JR et al. Inhalation anesthetics augment oxidant-induced pulmonary vasoconstriction: evidence for a membrane effect. 1985 Anesthesiology pmid:3933385
Munsterhjelm E et al. Dose-dependent inhibition of platelet function by acetaminophen in healthy volunteers. 2005 Anesthesiology pmid:16192763
Hudson JC et al. Ibuprofen pretreatment inhibits prostacyclin release during abdominal exploration in aortic surgery. 1990 Anesthesiology pmid:2106806
Horiguchi T et al. Heparin-protamine complexes cause pulmonary hypertension in goats. 1995 Anesthesiology pmid:7574058
Hirakata H et al. Propofol has both enhancing and suppressing effects on human platelet aggregation in vitro. 1999 Anesthesiology pmid:10551587
Heller A et al. Pancreatitis-associated protein protects the lung from leukocyte-induced injury. 1999 Anesthesiology pmid:10551593
Fratacci MD et al. Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. 1991 Anesthesiology pmid:1741521
Kurrek MM et al. Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb. 1995 Anesthesiology pmid:7832299
Uchida M et al. Changes in cerebral microcirculation during and after abdominal aortic cross-clamping in rabbits: the role of thromboxane A2 receptor. 2003 Anesth. Analg. pmid:12598238
Fomsgaard JS et al. Comparison of thromboxane synthetase inhibitor and methylprednisolone effects on protamine responses in dogs. 1992 Anesth. Analg. pmid:1734796
Gama de Abreu M et al. One-lung ventilation with high tidal volumes and zero positive end-expiratory pressure is injurious in the isolated rabbit lung model. 2003 Anesth. Analg. pmid:12505956
Tanus-Santos JE et al. The hemodynamic effects of endothelin receptor antagonism during a venous air infusion in dogs. 2000 Anesth. Analg. pmid:10624986
De la Cruz JP et al. Differences in the in vitro antiplatelet effect of dexibuprofen, ibuprofen, and flurbiprofen in human blood. 2010 Anesth. Analg. pmid:21048099
Brinkmann A et al. The impact of prostanoids on pulmonary gas exchange during abdominal surgery with mesenteric traction. 1997 Anesth. Analg. pmid:9249099
Thwaites BK et al. Intravenous ketorolac tromethamine worsens platelet function during knee arthroscopy under spinal anesthesia. 1996 Anesth. Analg. pmid:8638787
Matsumoto M et al. Lung traction causes an increase in plasma prostacyclin concentration and decrease in mean arterial blood pressure. 1992 Anesth. Analg. pmid:1416133
Shapira Y et al. Methylprednisolone does not decrease eicosanoid concentrations or edema in brain tissue or improve neurologic outcome after head trauma in rats. 1992 Anesth. Analg. pmid:1632538
Thwaites BK et al. Intravenous ketorolac tromethamine does not worsen platelet function during knee arthroscopy under general anesthesia. 1995 Anesth. Analg. pmid:7598238
Kawamoto M et al. Acute pulmonary edema after intravenous liquid halothane in dogs. 1992 Anesth. Analg. pmid:1567044
Byrick RJ et al. Ibuprofen pretreatment does not prevent hemodynamic instability after cemented arthroplasty in dogs. 1992 Anesth. Analg. pmid:1530164
Carroll RC et al. A comparison of VerifyNowR with PlateletMappingR--detected aspirin resistance and correlation with urinary thromboxane. 2013 Anesth. Analg. pmid:23302970
Mistakopulo NF et al. [The effect of indomethacin and leukinferon on the level of blood plasma thromboxane B2, platelet aggregation and the immune system of patients with endometrial cancer in the perioperative period]. 1992 Mar-Apr Anesteziol Reanimatol pmid:1416192
Abbakumov VV et al. [The prostacyclin-thromboxane system and platelet hemostasis following aortocoronary bypass with an uncomplicated postoperative course]. 1992 Sep-Dec Anesteziol Reanimatol pmid:1492691
Di Minno MN et al. Increased platelet reactivity in Klinefelter men: something new to consider. 2015 Andrology pmid:26216452
Bornman MS et al. Thromboxane B2 production during erection. 1986 Mar-Apr Andrologia pmid:3755013
Thunus L et al. Anti-inflammatory properties of copper, gold and silver, individually and as mixtures. 1995 Analyst pmid:7741265
Bollinger JG et al. Improved sensitivity mass spectrometric detection of eicosanoids by charge reversal derivatization. 2010 Anal. Chem. pmid:20704368
Schweer H et al. Tandem mass spectrometric determination of 11-dehydrothromboxane B2, an index metabolite of thromboxane B2 in plasma and urine. 1987 Anal. Biochem. pmid:3674365
Tai HH and Yuan B Development of radioimmunoassay for thromboxane B2. 1978 Anal. Biochem. pmid:567443
Fitzpatrick FA et al. A radioimmunoassay for thromboxane B2. 1977 Anal. Biochem. pmid:907115
Cavalca V et al. Simultaneous quantification of 8-iso-prostaglandin-F(2alpha) and 11-dehydro thromboxane B(2) in human urine by liquid chromatography-tandem mass spectrometry. 2010 Anal. Biochem. pmid:19825360
Chiabrando C et al. Antibody-mediated extraction/negative-ion chemical ionization mass spectrometric measurement of thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine. 1987 Anal. Biochem. pmid:3619026
Lawson JA et al. Long-lived enzymatic metabolites of thromboxane B2 in the human circulation. 1986 Anal. Biochem. pmid:3087234
Tewes KS et al. Measurement of thromboxane B2 in platelet-rich human plasma by gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry following extractive pentafluorobenzyl esterification. 1998 Anal. Biochem. pmid:9683522
Henke DC et al. Analysis of leukotrienes, prostaglandins, and other oxygenated metabolites of arachidonic acid by high-performance liquid chromatography. 1984 Anal. Biochem. pmid:6091494
Hayashi Y et al. Immunoaffinity purification of 11-dehydro-thromboxane B2 from human urine and plasma for quantitative analysis by radioimmunoassay. 1990 Anal. Biochem. pmid:2372112
Lawson JA et al. Measurement of urinary 2,3-dinor-thromboxane B2 and thromboxane B2 using bonded-phase phenylboronic acid columns and capillary gas chromatography--negative-ion chemical ionization mass spectrometry. 1985 Anal. Biochem. pmid:4091270
Riutta A et al. Solid-phase extraction of urinary 11-dehydrothromboxane B2 for reliable determination with radioimmunoassay. 1992 Anal. Biochem. pmid:1519756